Marinus Pharmaceuticals, Inc.
NASDAQ:MRNS
1.6 (USD) • At close September 19, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| -141.405 | -19.816 | -98.776 | -67.475 | -54.121 | -36.726 | -18.898 | -28.643 | -24.85 | -10.833 | -5.27 | -1.409 |
| Afschrijvingen & Amortisatie
| 0.551 | 0.418 | 0.355 | 0.334 | 0.278 | 0.127 | 0.126 | 0.023 | 0.011 | 0.005 | 0.01 | 0.018 |
| Uitgestelde Inkomstenbelasting
| 0.444 | 0 | -0.687 | 0.003 | 0.034 | 0 | -0.028 | 0 | 0.002 | -1.192 | -0.153 | -0.336 |
| Aandelen Gebaseerde Vergoedingen
| 15.563 | 14.89 | 13.867 | 7.642 | 5.672 | 4.788 | 2.88 | 3.077 | 2.108 | 0.698 | 0.236 | 0.121 |
| Verandering in Werkkapitaal
| 2.169 | -6.092 | 28.699 | -2.042 | -0.59 | 4.048 | -2.9 | 0.767 | 2.593 | 2.729 | -1.542 | 0.072 |
| Vorderingen
| 2.613 | -5.577 | -0.853 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Voorraden
| 0 | 0 | 0.853 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Crediteuren
| 2.108 | 3.754 | 7.841 | 1.877 | 0.89 | -2.121 | -2.121 | -0.629 | 3.54 | 1.385 | 0 | 0 |
| Overig Werkkapitaal
| -2.552 | -4.269 | 20.858 | -3.919 | -1.48 | 6.169 | -0.779 | 1.396 | -0.947 | 1.344 | -1.542 | 0.072 |
| Overige Niet-Contante Posten
| 4.677 | -102.286 | 1.065 | 0.626 | 0.094 | -0.079 | 0.004 | 0.007 | 0.007 | 0.004 | 0.09 | 0.305 |
| Kasstroom uit Operationele Activiteiten
| -118.001 | -112.886 | -55.477 | -60.912 | -48.633 | -27.842 | -18.816 | -24.769 | -20.129 | -8.589 | -6.628 | -1.228 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -0.119 | -1.774 | -2.889 | 0 | -0.388 | -0.083 | -0.45 | -0.644 | -0.352 | -0.033 | -0.017 | -0.005 |
| Netto Overnames
| 0.009 | 0.171 | 0 | 0 | -4.269 | 0 | 0 | 0 | 0.352 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -51.995 | -0.171 | 0 | -8.931 | -2.725 | -24.892 | -24.892 | -2.434 | -7.705 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 23.5 | 107.375 | 1.474 | 8.193 | 6.994 | 20 | 3.922 | 4.474 | 1.743 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| -28.486 | 0.171 | 1.474 | -0.738 | 4.269 | 24.892 | -20.97 | 2.04 | -0.352 | 0 | 0 | 0 |
| Kasstroom uit Investeringsactiviteiten
| -28.605 | 105.772 | -1.415 | -0.738 | 3.881 | 19.917 | -21.42 | 1.396 | -6.314 | -0.033 | -0.017 | -0.005 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| 0 | -0.042 | -40.111 | 0 | 0 | -0.193 | -5.247 | -2.128 | -0.206 | -6.975 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 26.627 | 64.477 | 1.199 | 108.196 | 67.968 | 42.314 | 52.643 | -0.043 | 28.651 | 41.202 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 4.806 | 60.303 | 80.222 | 1.02 | 67.968 | 42.314 | 52.836 | -0.043 | 28.651 | 7.103 | 8.048 | 8.882 |
| Kasstroom uit Financieringsactiviteiten
| 26.627 | 124.738 | 41.31 | 109.216 | 67.968 | 42.121 | 47.589 | -2.171 | 28.445 | 48.305 | 8.048 | 8.882 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 21.821 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -119.979 | 117.624 | -15.582 | 47.566 | 23.216 | 34.196 | 7.353 | -25.544 | 2.002 | 39.683 | 1.403 | 7.648 |
| Kaspositie aan het Einde van de Periode
| 120.572 | 240.551 | 122.927 | 138.509 | 90.943 | 67.727 | 33.531 | 26.178 | 51.722 | 49.72 | 10.037 | 8.634 |